RemeGen H Logo

RemeGen H

🇨🇳
09995
CNE1000048G6

RemeGen H, headquartered in China, is a leading biopharmaceutical company specializing in the research, development, and commercialization of innovative biologics. The company focuses on advancing novel therapies to address unmet medical needs in autoimmune diseases, oncology, and ophthalmology worldwide.

Next Quarterly Earnings

Wednesday, November 4, 2026
CW 45
Pre-Market
In 69 days

Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).

Quiet period starts on October 7, 2026

Stock Price

Frequently asked questions

When will RemeGen H report its next quarterly earnings?

RemeGen H is scheduled to report its next quarterly earnings on 11/04/2026. Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).

When did RemeGen H last report quarterly earnings?

RemeGen H last reported quarterly earnings on 8/24/2026 (Q2 2026).

How do I add the RemeGen H earnings dates to my calendar?

Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.

All Dates

Q3 2026
Estimate:
Actual:
Q2 2026
Estimate:
Actual:
Q1 2026
Estimate:
Actual:HK$0.66
Price reaction (1 day):-0.5 %
Price reaction (7 days):-7.4 %
Q4 2025
Beat
Estimate:-HK$0.09
Actual:HK$1.43
Difference:+HK$1.52
Price reaction (1 day):+6.3 %
Price reaction (7 days):+24.2 %

Company Information

Name
RemeGen H
Ticker Symbol
09995
ISIN
CNE1000048G6
Country
🇨🇳
China
Sector
More Financial Information